Research

Rather than treating each disease or tissue as a separate technology, we build reusable engineering platforms and apply them where spatial control and measurement over time matter.

Engineer

Microfluidic and organ-on-chip platforms that set the conditions living tissue experiences.

Model

Human tissues and organoids, grown alone or with microbes.

Measure

Continuous on-chip sensors that track what tissue secretes, such as albumin and cholesterol, over time.

Cross-section of a two-compartment organ-on-chip: tissue lining the upper channel, a perfused channel carrying microbes below, and a porous membrane between them
Inside a two-compartment chip: tissue lines the upper channel, a perfused channel runs below, and a porous membrane between them lets molecules cross.
Brightfield image of an organoid with fluorescent bacteria nearby

Microbes and colorectal cancer

The colon is lined by epithelium that lives in constant contact with bacteria and the molecules they make. We build colon organoid models and microfluidic chips in which living bacteria and human epithelium share the same space, so their interactions can be controlled and measured.

Current work asks how bile salts, bacterial enzymes such as bile salt hydrolase, and other microbial metabolites influence bacterial colonization, host signaling and tumor behavior in colorectal cancer organoids.

Selected papers

  1. 2026
  2. 2024

    Engineered bacterial therapeutics for detecting and treating CRC

    Siguenza N, Brevi A, Zhang JT, Pabani A, Bhushan A, Das M, Ding Y, Hasty J, Ghosh P, Zarrinpar A

    Trends in Cancer 10(7): 588–597, 2024

    doi.org/10.1016/j.trecan.2024.04.001

  3. 2024
  4. 2018

    A novel microfluidic colon with an extracellular matrix membrane

    Wang C, Tanataweethum N, Karnik S, Bhushan A

    ACS Biomaterials Science and Engineering 4(4): 1377–1385, 2018

    doi.org/10.1021/acsbiomaterials.7b00883

Fluorescence image of adipocytes cultured on a chip

Liver–fat crosstalk

Fat tissue and the liver signal to each other constantly, and that conversation goes wrong in insulin resistance and fatty liver disease. We culture adipose and liver tissues on chip to study it with human and primary cells under flow.

Our perfused adipose tissue-chips carry preadipocytes differentiated into adipocytes, and adipocytes made insulin resistant. The insulin-resistant adipocytes take up less fatty acid, and rosiglitazone restores uptake. Our liver constructs combine several cell types, stay functional for weeks, and can be made insulin resistant to test strategies that restore insulin response.

Selected papers

  1. 2021

    Investigation of insulin resistance through a multiorgan microfluidic organ-on-chip

    Tanataweethum N, Trang A, Lee C, Mehta J, Patel N, Cohen RN, Bhushan A

    Biomedical Materials 17(2): 025002, 2021

    doi.org/10.1088/1748-605X/ac4611

  2. 2020

    A 3D human adipose tissue model within a microfluidic device

    Yang F, Carmona A, Stojkova K, Huitron EI, Goddi A, Bhushan A, Cohen RN, Brey EM

    Lab on a Chip 21(2): 435–446, 2020

    doi.org/10.1039/D0LC00981D

  3. 2020

    Towards an insulin resistant adipose model on a chip

    Tanataweethum N, Zhong F, Trang A, Lee C, Cohen RN, Bhushan A

    Cellular and Molecular Bioengineering 14(1): 89–99, 2020

    doi.org/10.1007/s12195-020-00636-x

  4. 2018

    Establishment and characterization of a primary murine adipose tissue-chip

    Tanataweethum N, Zelaya A, Yang F, Cohen RN, Brey EM, Bhushan A

    Biotechnology and Bioengineering 115(8): 1979–1987, 2018

    doi.org/10.1002/bit.26711

  5. 2015

    Long-term maintenance of a microfluidic 3D human liver sinusoid

    Prodanov L, Jindal R, Bale SS, Hegde M, McCarty WJ, Golberg I, Bhushan A, Yarmush ML, Usta OB

    Biotechnology and Bioengineering 113(1): 241–246, 2015

    doi.org/10.1002/bit.25700

Fluorescence image of bacteria colonizing intestinal cells

Microbiome and drug response

Gut bacteria change how drugs are absorbed and metabolized. Our intestine tissue chip grows a tight epithelial monolayer on a collagen membrane instead of the usual Transwell membrane, and we use it to study how gut bacteria modulate cytochrome P450 drug-metabolizing enzymes. Because many gut bacteria need low oxygen, we also built chips with local control of oxygen tension.

We pair these experiments with pharmacokinetic models to understand how bacteria alter drug exposure, for example for tacrolimus and sulfasalazine.

Selected papers

  1. 2024
  2. 2022

    Causative role of anoxic environment in bacterial regulation of human intestinal function

    Wang C, Cancino A, Baste J, Marten D, Joshi AA, Nasreen A, Bhushan A

    Cellular and Molecular Bioengineering 15(5): 493–504, 2022

    doi.org/10.1007/s12195-022-00735-x

  3. 2021
  4. 2016

    New technologies in drug metabolism and toxicity screening: organ-to-organ interaction

    Bhushan A, Martucci NJ, Usta OB, Yarmush ML

    Expert Opinion on Drug Metabolism & Toxicology 12(5): 475–477, 2016

    doi.org/10.1517/17425255.2016.1162292

  5. 2013

    Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humans

    Bhushan A, Senutovitch N, Bale SS, McCarty WJ, Hegde M, Jindal R, Golberg I, Berk Usta O, Yarmush ML, Vernetti L, Gough A, Bakan A, Shun T, Biasio R, Lansing Taylor D

    Stem Cell Research & Therapy 4(S1): S16, 2013

    doi.org/10.1186/scrt377

Diagram of a microfluidic bead assay: a cell culture chamber feeds bead and antibody inlets, two serpentine mixers and a detection region

On-chip sensing

Tissue on a chip changes over days and weeks, and the small volumes make proteins and small molecules hard to measure. We build assays into the chip that read out what cells secrete in real time, without stopping the experiment. Bead-based assays run in line with the culture chamber and measure secreted proteins and metabolites, such as albumin and cholesterol.

Measuring over time turns an organ-on-chip from a single snapshot into a record of how tissue responds to drugs, microbes and nutrients.

Selected papers

  1. 2019
  2. 2017

    A microfluidic in-line ELISA for measuring secreted proteins under perfusion

    Luan Q, Cahoon S, Wu A, Bale SS, Yarmush ML, Bhushan A

    Biomedical Microdevices 19(4): 101, 2017

    doi.org/10.1007/s10544-017-0244-6

  3. 2014

    A highly sensitive microsphere-based assay for early detection of Type I diabetes

    Bale SS, Price G, Casali M, Saeidi N, Bhushan A, Yarmush ML

    Technology 2(3): 200–205, 2014

    doi.org/10.1142/S2339547814500174

  4. 2011

    Microparticles and Microfluidics Merged: Perspectives of Highly Sensitive Diagnostic Detection

    Konry T, Bale SS, Bhushan A, Shen K, Polyak B

    Microchimica Acta 176(3-4): 251–269, 2011

    doi.org/10.1007/s00604-011-0705-1

A microfabricated metal gas chromatography column next to a penny

Other and earlier projects

Past and collaborative projects include a patient-derived pancreatic cancer-on-a-chip for testing combination drugs, a point-of-care saliva test for periodontitis, analysis of volatile compounds in breath and other samples, and microfabricated columns for gas chromatography.

Watch and read